Non-GAAP Financial MeasuresIn addition to disclosing financial results calculated in accordance with accounting principles generally accepted in the U.S. (GAAP), this release contains non-GAAP financial measures. The comparisons of revenue for the three and nine months ended September 30, 2010 and 2009 that exclude the changes in accounting estimates for each period are non-GAAP financial measures. The Company believes that the non-GAAP financial measures included in this release provide meaningful supplemental information to both management and investors that is indicative of the Company's core operating results. The Company further believes these non-GAAP financial measures facilitate comparison of operating results across reporting periods, and uses these non-GAAP financial measures when evaluating its financial results, as well as for internal planning and forecasting purposes. These non-GAAP financial measures should not be considered a substitute for, or superior to, financial measures calculated in accordance with GAAP that are also included in this release.
Forward-Looking StatementsThis press release contains forward-looking statements within the meaning of the U.S. Private Securities Litigation Reform Act of 1995. Any statements in this press release regarding the Company's business that are not historical facts may be considered "forward-looking statements," including statements regarding the value of the Company's services, the Company's ability to focus on the needs of community-based hematologists and oncologists, to provide high quality and more comprehensive diagnostic services and to address and adapt to the changing environment, the success of the Company's business model, the Company's ability to optimize the care of patients and have adequate capacity to
|SOURCE Genoptix, Inc.|
Copyright©2010 PR Newswire.
All rights reserved